Lower pretreatment HBV DNA levels are associated with better off-treatment outcomes after nucleo(s)tide analogue withdrawal in patients with HBeAg-negative chronic hepatitis B: A multicentre cohort study
Titel:
Lower pretreatment HBV DNA levels are associated with better off-treatment outcomes after nucleo(s)tide analogue withdrawal in patients with HBeAg-negative chronic hepatitis B: A multicentre cohort study
Auteur:
Sonneveld, Milan J. Chiu, Shao-Ming Park, Jun Yong Brakenhoff, Sylvia M. Kaewdech, Apichat Seto, Wai-Kay Tanaka, Yasuhito Carey, Ivana Papatheodoridi, Margarita Colombatto, Piero van Bömmel, Florian Berg, Thomas Zoulim, Fabien Ahn, Sang Hoon Dalekos, George N. Erler, Nicole S. Brunetto, Maurizia Wedemeyer, Heiner Cornberg, Markus Yuen, Man-Fung Agarwal, Kosh Boonstra, Andre Buti, Maria Piratvisuth, Teerha Papatheodoridis, George Chen, Chien-Hung Maasoumy, Benjamin